scholarly article | Q13442814 |
P2093 | author name string | Sophie J. Bakri | |
Paul M. Beer | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 386-390 | |
P577 | publication date | 2003-09-01 | |
P1433 | published in | Ophthalmic Surgery, Lasers and Imaging | Q15759088 |
P1476 | title | The effect of intravitreal triamcinolone acetonide on intraocular pressure | |
P478 | volume | 34 |
Q39010103 | A Review of the Role of Intravitreal Corticosteroids as an Adjuvant to Antibiotics in Infectious Endophthalmitis. |
Q34107543 | A prospective, randomized comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab (avastin) in diffuse diabetic macular edema |
Q42634677 | Comparison of 4 mg versus 20 mg intravitreal triamcinolone acetonide injections |
Q49385210 | Comparison of Intravitreal Bevacizumab and Intravitreal Diclofenac in the Treatment of Diabetic Macular Edema: a 6-month Follow-up |
Q37233253 | Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone |
Q45022313 | Diffuse diabetic macular edema. Intraocular pressure after intravitreal triamcinolone acetonide |
Q37577445 | Intracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucoma |
Q35762005 | Intraocular pressure alterations following intravitreal triamcinolone acetonide |
Q36622491 | Intraocular pressure elevation after intravitreal triamcinolone acetonide injection: a Meta-analysis |
Q43257000 | Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes. |
Q42840700 | Intravitreal anti-inflammatory treatment for uveitis |
Q59101228 | Intravitreal steroids for the treatment of retinal diseases |
Q44780849 | Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases |
Q79566841 | Intravitreal triamcinolone acetonide in the management of cystoid macular edema in Behçet's disease |
Q37221486 | Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors. |
Q33281020 | Long-term effects of radial optic neurotomy for central retinal vein occlusion consecutive interventional case series |
Q36055455 | Management of sight-threatening uveitis: new therapeutic options. |
Q44780851 | Ocular side effects and complications of intravitreal triamcinolone acetonide injection |
Q35769376 | Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye |
Q35956280 | Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study |
Q35030923 | Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis). |
Q60957105 | The Effects of Intravitreal Ranibizumab, Aflibercept or Dexamethasone Implant Injections on Intraocular Pressure Changes |
Q47145465 | Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone |
Q34014954 | Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis |
Q81228550 | [Intraocular pressure related to uveitis] |
Search more.